Allan Reine Prime Medicine, Inc. (PRME) insider trading activity

PRME Quotes by TradingView

Allan Reine is Chief Executive Officer of Prime Medicine, Inc.. Currently has a direct ownership of 125,000 shares of PRME, which is worth approximately $146,250. The most recent transaction as insider was on May 21, 2025, when has been sold 125,000 shares (Common Stock) at a price of $1.18 per share, resulting in proceeds of $147,500. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 125K
n/a 3M change
n/a 12M change
Total Value Held $146,250

Allan Reine Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 21 2025
BUY
Open market or private purchase
$147,500 $1.18 p/Share
125,000 Added 50.0%
125,000 Common Stock

Also insider at

FHTX
Foghorn Therapeutics Inc. Healthcare
Chief Financial Officer
AR

Allan Reine

Chief Executive Officer
Cambridge, MA

Track Institutional and Insider Activities on PRME

Follow Prime Medicine, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells PRME shares.

Notify only if

Insider Trading

Get notified when an Prime Medicine, Inc. insider buys or sells PRME shares.

Notify only if

News

Receive news related to Prime Medicine, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on PRME